Guangdong Golden Dragon Development Valuation
Is 000712 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 000712 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 000712's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 000712's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 000712?
Other financial metrics that can be useful for relative valuation.
What is 000712's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | CN¥11.60b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | n/a |
Enterprise Value/EBITDA | n/a |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 000712's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 3.6x | ||
002961 Ruida FuturesLtd | 4.3x | 7.2% | CN¥7.5b |
603093 Nanhua Futures | 1.3x | 8.5% | CN¥7.7b |
002926 HUAXI Securities | 8x | 4.2% | CN¥22.5b |
600927 Yongan FuturesLtd | 0.9x | 8.5% | CN¥21.0b |
000712 Guangdong Golden Dragon Development | 22.3x | -3.5% | CN¥11.6b |
Price-To-Sales vs Peers: 000712 is expensive based on its Price-To-Sales Ratio (22.3x) compared to the peer average (3.6x).
Price to Earnings Ratio vs Industry
How does 000712's PE Ratio compare vs other companies in the CN Capital Markets Industry?
Price-To-Sales vs Industry: 000712 is expensive based on its Price-To-Sales Ratio (22.3x) compared to the CN Capital Markets industry average (7.6x).
Price to Sales Ratio vs Fair Ratio
What is 000712's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 22.3x |
Fair PS Ratio | 1.9x |
Price-To-Sales vs Fair Ratio: 000712 is expensive based on its Price-To-Sales Ratio (22.3x) compared to the estimated Fair Price-To-Sales Ratio (1.9x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.